Catalyst Wire Dossier Catalyst Wire Dossier

Seletracetam

Seletracetam · UCB Pharma
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Seletracetam, covering 2012-03-20 to 2024-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures [Phase 2]

See pricing